Skandinaviska Enskilda Banken Ab (Publ) Adaptive Biotechnologies Corp Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

  • $21.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$3.46 - $5.33 $58,474 - $90,077
-16,900 Reduced 30.12%
39,200 $192,000
Q3 2023

Nov 09, 2023
SELL
$5.07 - $8.44 $57,798 - $96,216
-11,400 Reduced 16.89%
56,100 $306,000
Q2 2023

Aug 07, 2023
BUY
$6.19 - $8.78 $87,279 - $123,797
14,100 Added 26.4%
67,500 $453,000
Q1 2023

May 11, 2023
BUY
$7.8 - $10.11 $416,520 - $539,874
53,400 New
53,400 $472,000

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email